US3629142A - Reference standard blood serum for the calibration of automatic blood serum analyzing apparatus - Google Patents

Reference standard blood serum for the calibration of automatic blood serum analyzing apparatus Download PDF

Info

Publication number
US3629142A
US3629142A US883286A US3629142DA US3629142A US 3629142 A US3629142 A US 3629142A US 883286 A US883286 A US 883286A US 3629142D A US3629142D A US 3629142DA US 3629142 A US3629142 A US 3629142A
Authority
US
United States
Prior art keywords
serum
blood serum
reference standard
reconstituted
tris
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US883286A
Inventor
Edward P Marbach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EDWARD P MARBACH
Bayer Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of US3629142A publication Critical patent/US3629142A/en
Assigned to COOPER LABORATORES, INC. reassignment COOPER LABORATORES, INC. ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: BAXTER TRAVENOL LABORATORIES, INC., A CORP. OF DE
Assigned to TECHNICON INSTRUMENTS CORPORATION, 511 BENEDICT AVENUE, TARRYTOWN, NEW YORK 10591-6097, A CORP. OF DE. reassignment TECHNICON INSTRUMENTS CORPORATION, 511 BENEDICT AVENUE, TARRYTOWN, NEW YORK 10591-6097, A CORP. OF DE. ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: COOPER LABORATORIES, INC.,
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/05—Reference solutions for assays of biological material containing blood cells or plasma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/102499—Blood gas standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/103332—Bilirubin or uric acid standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/104165—Lipid, cholesterol, or triglyceride standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/104998—Glucose, ketone, nitrate standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664—Blood serum or blood plasma standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/109163—Inorganic standards or controls

Definitions

  • the Tris carbonate serves to produce a carbon dioxide content in the reconstituted reference standard serum which is suitable for standardizing and calibrating the test equipment.
  • the Tris carbonate is colorless and has no turbid characteristics as would affect any of the tests made by the aforesaid apparatus.

Abstract

A FREEZE-DRIED BLOOD SERUM IS PROVIDED FOR USE AS A REFERENCE STANDARD IN THE CALIBRATION OF AUTOMATIC BLOOD SERUM ANALYZING APPARATUS, COMPRISING A HUMAN SERUM IN WHICH THE LEVELS OF COMCENTRATION OF ITS CONSTITUENTS HAVE BEEN PRECISELY ADJUSTED, AND WHICH IS SPECIALLY PROCESSED FOR USE IN APPARATUS FOR THE SIMULTANEOUS ANALYSIS OF THE CONSTITUENTS OF EACH OF A SUCCESSION OF BLOOD SERUM SAMPLES. THE REFERENCE STANDARD BLOOD SERUM OF THE INVENTION CONTAINS TRIHYDROXYMETHYLAMINE (TRIS) CARBONATE SO AS TO PERMIT IT TO BE RECONSTITUTED JUST PRIOR TO USE WITH DISTILLED WATER SO AS TO RESTORE A PREDETERMINED CARBON DIOXIDE LEVEL IN THE REFERENCE SERUM. ALTERNATELY, THE REFERENCE STANDARD BLOOD SERUM CONTAINS. TRIS, AND IS RECONSTITUTED WITH DISTILLED WATER AND CARBON DIOXIDE.

Description

United States Patent 3,629,142 REFERENCE STANDARD BLOOD SERUM FOR THE CALIBRATION OF AUTOMATIC BLOOD SERUM ANALYZING APPARATUS Edward P. Marbach, 4607 Marwood Drive, Los Angeles, Calif. 90065 No Drawing. Filed Dec. 8, 1969, Ser. No. 883,286 Int. Cl. G01n 31/22, 33/16 US. Cl. 252-408 5 Claims ABSTRACT OF THE DISCLOSURE A freeze-dried blood serum is provided for use as a reference standard in the calibration of automatic blood serum analyzing apparatus, comprising a human serum in which the levels of concentration of its constituents have been precisely adjusted, and which is specially processed for use in apparatus for the simultaneous analysis of the constituents of each of a succession of blood serum samples. The reference standard blood serum of the invention contains trihydroxymethylamine (Tris) carbonate so as to permit it to be reconstituted just prior to use with distilled water so as to restore a predetermined carbon dioxide level in the reference serum. Alternately, the reference standard blood serum contains Tris, and is reconstituted with distilled water and carbon dioxide.
BACKGROUND OF THE INVENTION Various types of apparatus have been developed in recent years for the automatic analysis of human blood serum, and which are capable of making rapid simultaneous analytical determinations on a precise quantitative basis of various components of each of a series of blood serum samples successively introduced into the apparatus. Biochemical determinations may be made, for example, by such apparatus, of the following constituents of the blood serum samples: albumin, alkaline phosphatase, bilirubin, calcium, chloride, cholesterol, carbon dioxide content, creatinine, glucose, lactic dehydrogenase (LDH), inorganic phosphorus, potassium, sodium, total protein, transaminase (SGOT), urea nitrogen, uric acid, creatine phosphokinase (CPK).
The aforesaid apparatus may be of the type described, for example, in the Skeggs et a1. Pat. 3,241,432 which issued Mar. 22, 1966, and which is assigned to the Technicon Instruments Corporation of Chauncey, N.Y. The Skeggs apparatus, for example, is capable of making simultaneously a multiplicity of different analyses of a blood serum sample, with respect to the constituents referred to, for example, in the preceding paragraph, and of rapidly repeating the analyses on successive samples.
In the operation of the apparatus described in the Skeggs patent, for example, a series of individual separate blood serum samples are successively introduced into the machine, and are formed into a stream which subsequently is divided into a plurality of separate streams, depending upon the number of separate tests to be made. Each of the streams is separately treated for quantitative analysis with respect to the particular constituents, and the results of the analyses are recorded, for example, on a chart of a recorder, or are otherwise stored in any prescribed correlated form.
As is well known, the determination of the carbon dioxide content of the blood is of great importance in many clinical procedures. The aforesaid apparatus is capable of determining the carbon dioxide content of the test sample. Therefore, it is important for the reference standard blood serum to include a predetermined carbon dioxide content so that it may be used to calibrate the apparatus for that particular determination. However, it
3,629,142 Patented Dec. 21, 1971 has been found that in the freeze-drying of the blood serum for reference standard purposes, a substantial amount of carbon dioxide content of the serum is lost in the form of gaseous CO In order to calibrate apparatus of the type described in the aforesaid patent, a reference standard blood serum sample is used whose constituents have precisely predetermined values. It is necessary for such reference standard serums to be capable of being stored for long periods of time without deterioration, and for that reason it has been the practice to freeze-dry them. It has also been the prior art practice to reconstitute the reference standard serum before use by means, for example, of a separate aqueous solution of ammonium bicarbonate, to restore the carbon dioxide level to a predetermined value.
However, a problem which has arisen when the abovedescribed prior art reference standard serum is used is that a separate vial of a measured amount of the ammonium bicarbonate solution had to be provided, and reliance had to be placed on the ultimate user that the reconstituting solution would be added in the proper quantity to the reference standard serum. This makes the reliability of the results of the apparatus dependent upon the ultimate user.
Moreover, when the prior reference standard serum is to be used for different analytical procedures, different levels of carbon dioxide contents are required, and this calls for different concentrations of the reconstituting solution. In such cases, different vials of different concentrations of the ammonium bicarbonate solution must be provided with the prior art reference standard blood serum, and there is no assurance that the ultimate user would use the proper vial of the reconstituting solution for the appropriate procedure.
The prior art provision of the separate aqueous solution of the ammonium bicarbonate for the reconstitution of the freeze-dried serum just prior to use is necessary, because the reconstituted prior art serum was found to be stable only for a few days, and then only if stored in refrigeration between, for example, 2 and 8 centigrade. It was found, for example, that storage of the reconstituted prior art reference serum at room temperature tended to alter the SGOT and LDH value in the reconstituted serum.
Also the ammonium bicarbonate could not be intermixed into the prior art reference serum originally in the laboratory because it is completely lost during freeze drying.
An important object of the present invention is to provide a reference standard serum to which a carbonate or bicarbonate of Tris(hydroxymethyl) aminomethane is added prior to when it is in its freeze-dried state, and which may be reconstituted merely by adding distilled water. The Tris carbonate has no effect on any of the constituents of the reference standard serum and does not affect the stability of its enzyme constituents in any way, even over long intervals of time. The use of Tris carbonate takes the concentration control of the reconstituting element out of the hands of the ultimate user, and into the laboratory where it can be established precisely and under optimum environmental conditions. The chemical name is 2-amino-2-(hydroxymethyl)-1,3-propandiol. The formula is It has been found that the use of the Tris carbonate reference standard serum of the present invention results in a reconstituted serum by the addition of distilled water, which functions with all the efficacy of the properly re constituted prior art ammonium bicarbonate reference standard serum. The reference standard serum of the present invention has no tendency to plug the apparatus in which it is used, and it is clear and colorless. so that it does not affect any of the colorimeter or other tests carried out by the apparatus. The use of Tris carbonate in the reference standard serum of the invention results in a proper pH, so that the stability of enzymes such as lactic dehydrogenase and transaminase, is in no way affected.
An important feature of the present invention is that the addition of a measured amount of Tris carbonate to the reference standard serum permits the carbonate dioxide content to be restored to any predetermined level upon reconstitution of the serum by the addition of distilled water, and as determined by the concentration of the Tris carbonate, depending upon the particular analytical procedure in which the reference standard serum is to be used.
The freeze-dried serum used in the practice of the invention can be prepared by any conventional method of freeze-drying whereby human serum is dried from a frozen state under high vacuum; wherein ice, or other frozen solvents, rapidly sublime to yield a porous solid. The resulting freeze-dried reference standard serum has been found to remain stable for over two years at temperatures ranging from 2 C. to C. In the practice of the invention, a quantity of Tris carbonate is added to the serum prior to freeze-drying; and the freeze-dried serum is subsequently reconstituted by the addition of distilled water prior to use. Alternately, Tris itself is added to the serum and carbon dioxide gas is bubbled into the serum prior to freeze-drying.
This reconstituting of the serum is necessary, as explained above, in order to increase the carbon dioxide content of the reconstituted serum to a predetermined level. as determined by the particular analytical procedure in which the serum is to be used for calibrating purposes. The reconstituted serum can be used directly for the calibration and control of the aforesaid apparatus.
The Tris carbonate is ideally suited as a component of the reference standard blood serum in that it does not affect in any way the precisely predetermined values of any of the constituents of the reference standard blood serum. Also, it imparts a normal pH to the serum so as to provide for the stability of its constituents, and particularly the enzymes, as mentioned above.
As explained above, the Tris carbonate serves to produce a carbon dioxide content in the reconstituted reference standard serum which is suitable for standardizing and calibrating the test equipment. As also previously stated, the Tris carbonate is colorless and has no turbid characteristics as would affect any of the tests made by the aforesaid apparatus.
The following specific example is intended to illustrate a particular reference serum illustrative of the practice of the invention.
As a first step in the preparation of the reference serum of the invention, selected samples of human blood serum were pooled. Then the Tris carbonate was added in sufficient amount to provide the desired carbon dioxide level in the reconstituted serum. For example, the Tris carbonate was formed by adding Dry Ice, as a source of carbon dioxide, to Tris. In a particular example, 65 grams of Tris was placed in 100 cc. of water, a quantity of Dry Ice was added, and the solution was allowed to stand overnight to permit the Tris carbonate to precipitate. The Tris carbonate was then dissolved in water, and added to the serum in a proportion of 7 grams of Tris carbonate per liter of serum, or in other proportions depending upon the exact level the carbon dioxide constituent of the serum is to be reconstituted. A volume of 50 milliliters of the serum and Tris carbonate mixture was then freeze-dried by a known freeze-drying process.
The freeze-dried serum, prior to use, was reconstituted by adding 50 milliliters of distilled water to a bottle containing the serum. The resulting mixture was slightly agitated by rotation of the bottle so that the serum was completely dissolved. The reconstituted pool was then analyzed by known procedures.
One specific sample of the reconstituted serum had the following constituent values which are listed herein merely by way of example:
Constituent: Value Glucose 230 mg./l00 ml. Blood urea nitrogen 69 mg./ ml. Potassium 5.4 m. eq./liter Sodium 149 m. eq./liter Carbon dioxide 30 m. eq./liter Chloride 113 m. eq./liter Alkaline phosphatase 25 KA units Transaminase (SGOT) 93 KA units Calcium 10.2 mg./l00 mil Phosphorous 4.8 mg./1()0 mil Uric acid 4.2 mg./l00 mil Cholesterol 200 mg./l00 mil Total protein 6.6 gm./l00 mil Albumin 3.9 gm./l00 mil Bilirubin 2.0 mg./l00 mil Lactic dehydrogenase 220 Wacker units What is claimed is:
1. A freeze-dried blood serum reference standard comprising blood serum having constituents of known values and a carbonate or bicarbonate Tristhydroxymethyl) aminomethane.
2. The blood serum of claim 1, in which the concentration of the aforesaid aminomethane in the serum is such that when the serum is reconstituted, the carbon dioxide content of the reconstituted serum is in a range extending from approximately 12 to approximately 35 m. eq./liter.
3. The blood serum of claim 1, reconstituted by the addition of distilled water.
4. The method of providing an accurate blood serum reference standard having a standard carbon dioxide content for use in multi-automated analytical procedures which comprises reconstituting freeze-dried blood serum containing a quantity of a carbonate or bicarbonate of Tris(hydroxymethyl)aminomethane with distilled water so that the carbon dioxide content of the reconstituted serum may be increased to a predetermined level.
5. The method set forth in claim 4, in which the concentration of the aforesaid aminomethane is such that the carbon dioxide content of the reconstituted serum is in a range extending from approximately 12 to approximately 35 m. eq./liter.
References Cited UNITED STATES PATENTS 3,466,249 9/1969 Anderson 252-408 JOHN T. GOOLKASIAN, Primary Examiner M. E. MCCAMISH, Assistant Examiner US. Cl. X.R. 23-230 B
US883286A 1969-12-08 1969-12-08 Reference standard blood serum for the calibration of automatic blood serum analyzing apparatus Expired - Lifetime US3629142A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88328669A 1969-12-08 1969-12-08

Publications (1)

Publication Number Publication Date
US3629142A true US3629142A (en) 1971-12-21

Family

ID=25382321

Family Applications (1)

Application Number Title Priority Date Filing Date
US883286A Expired - Lifetime US3629142A (en) 1969-12-08 1969-12-08 Reference standard blood serum for the calibration of automatic blood serum analyzing apparatus

Country Status (1)

Country Link
US (1) US3629142A (en)

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3859049A (en) * 1973-09-14 1975-01-07 Arnold G Ware Blood reference standard and process for blood gas test
US3876375A (en) * 1971-11-22 1975-04-08 Jonas Maurukas Biological composition for use as a reference control in diagnostic analysis
US3897363A (en) * 1973-08-10 1975-07-29 Baxter Laboratories Inc Blood control standard
US3977995A (en) * 1974-10-17 1976-08-31 Baxter Laboratories, Inc. Calibrating fluid for blood cell counting and hemoglobin determination
US4020006A (en) * 1975-08-14 1977-04-26 Icl/Scientific Fluid containing dispersed particles simulating leukocytes and method for producing same
US4054488A (en) * 1975-08-14 1977-10-18 Marbach Edward P Preservation of glucose in blood samples
US4056484A (en) * 1974-12-31 1977-11-01 Behringwerke Aktiengesellschaft Stable blood plasma, process for preparing it and its use as comparative plasma in coagulation tests
DE2723070A1 (en) * 1976-05-24 1977-12-15 Dorwart Jun REFERENCE PREPARATION FOR DETERMINING ANION CONCENTRATION IN CHEMICAL ANALYZES
US4121905A (en) * 1977-08-22 1978-10-24 Jonas Maurukas Process for preparing biological compositions for use as reference controls in diagnostic analyses
US4141856A (en) * 1976-05-24 1979-02-27 Dorwart Jr William V Reference material for establishing anion concentrations in analytical chemistry tests
US4158544A (en) * 1978-07-17 1979-06-19 Beckman Instruments, Inc. Process for preparing a biological composition for use as a reference control in diagnostic analysis
EP0016573A1 (en) * 1979-03-05 1980-10-01 Beckman Instruments, Inc. Enzyme reference composition
US4299728A (en) * 1980-07-21 1981-11-10 Instrumentation Laboratory Inc. Blood gas control
US4323478A (en) * 1977-01-18 1982-04-06 Baxter Travenol Laboratories, Inc. Novel particulate compositions
US4324685A (en) * 1978-07-17 1982-04-13 Beckman Instruments, Inc. Blood serum reference standard
US4325832A (en) * 1979-03-05 1982-04-20 Beckman Instruments, Inc. Enzyme reference composition
US4369127A (en) * 1980-07-21 1983-01-18 Instrumentation Laboratory Inc. Blood gas control
US4448888A (en) * 1982-08-24 1984-05-15 Bio-Rad Laboratories, Inc. Compositions and method for correcting temperature dependence of hemoglobin assays
US4716119A (en) * 1981-02-25 1987-12-29 Boehringer Mannheim Gmbh Control serum and process therefor
US4806486A (en) * 1985-01-31 1989-02-21 Stichting Gastransport Calibration liquid for ion-specific electrodes, process for preparing them and their application
US4871678A (en) * 1985-04-24 1989-10-03 Beschrankter Haftung Agent and process for the determination of calcium
US4956299A (en) * 1986-12-31 1990-09-11 Ciba Corning Diagnostics Corp. Complement stabilization
US5238845A (en) * 1991-08-02 1993-08-24 Instrumentation Laboratory S.P.A. Method for producing a co2 calibration liquid
US5385844A (en) * 1993-04-22 1995-01-31 Boehringer Mannheim Corporation Polymer containing control reagents and polymers useful in control reagents
US6268481B1 (en) 1997-05-29 2001-07-31 Medical Analysis Systems, Inc. Covalently coupled troponin complexes
US11604026B2 (en) 2019-03-14 2023-03-14 Terumo Bct Biotechnologies, Llc Lyophilization loading tray assembly and system
US11634257B2 (en) 2017-10-09 2023-04-25 Terumo Bct Biotechnologies, Llc Lyophilization container and method of using same

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3876375A (en) * 1971-11-22 1975-04-08 Jonas Maurukas Biological composition for use as a reference control in diagnostic analysis
US3897363A (en) * 1973-08-10 1975-07-29 Baxter Laboratories Inc Blood control standard
US3859049A (en) * 1973-09-14 1975-01-07 Arnold G Ware Blood reference standard and process for blood gas test
US3977995A (en) * 1974-10-17 1976-08-31 Baxter Laboratories, Inc. Calibrating fluid for blood cell counting and hemoglobin determination
US4056484A (en) * 1974-12-31 1977-11-01 Behringwerke Aktiengesellschaft Stable blood plasma, process for preparing it and its use as comparative plasma in coagulation tests
US4054488A (en) * 1975-08-14 1977-10-18 Marbach Edward P Preservation of glucose in blood samples
US4020006A (en) * 1975-08-14 1977-04-26 Icl/Scientific Fluid containing dispersed particles simulating leukocytes and method for producing same
DE2723070A1 (en) * 1976-05-24 1977-12-15 Dorwart Jun REFERENCE PREPARATION FOR DETERMINING ANION CONCENTRATION IN CHEMICAL ANALYZES
FR2353060A1 (en) * 1976-05-24 1977-12-23 Dorwart Jr William BLOOD SERUM STANDARD AND PREPARATION METHOD
US4141856A (en) * 1976-05-24 1979-02-27 Dorwart Jr William V Reference material for establishing anion concentrations in analytical chemistry tests
US4323478A (en) * 1977-01-18 1982-04-06 Baxter Travenol Laboratories, Inc. Novel particulate compositions
US4121905A (en) * 1977-08-22 1978-10-24 Jonas Maurukas Process for preparing biological compositions for use as reference controls in diagnostic analyses
WO1979000106A1 (en) * 1977-08-22 1979-03-08 J Maurukas Process for preparing biological compositions for use as a reference control in diagnostic analysis
DE2856988C1 (en) * 1977-08-22 1984-01-26 Jonas Elyria Ohio Maurukas Process for the preparation of biological compositions for use as reference control samples in diagnostic analysis
US4324685A (en) * 1978-07-17 1982-04-13 Beckman Instruments, Inc. Blood serum reference standard
US4158544A (en) * 1978-07-17 1979-06-19 Beckman Instruments, Inc. Process for preparing a biological composition for use as a reference control in diagnostic analysis
EP0016573A1 (en) * 1979-03-05 1980-10-01 Beckman Instruments, Inc. Enzyme reference composition
US4325832A (en) * 1979-03-05 1982-04-20 Beckman Instruments, Inc. Enzyme reference composition
US4299728A (en) * 1980-07-21 1981-11-10 Instrumentation Laboratory Inc. Blood gas control
US4369127A (en) * 1980-07-21 1983-01-18 Instrumentation Laboratory Inc. Blood gas control
US4716119A (en) * 1981-02-25 1987-12-29 Boehringer Mannheim Gmbh Control serum and process therefor
US4448888A (en) * 1982-08-24 1984-05-15 Bio-Rad Laboratories, Inc. Compositions and method for correcting temperature dependence of hemoglobin assays
US4806486A (en) * 1985-01-31 1989-02-21 Stichting Gastransport Calibration liquid for ion-specific electrodes, process for preparing them and their application
US4871678A (en) * 1985-04-24 1989-10-03 Beschrankter Haftung Agent and process for the determination of calcium
US4956299A (en) * 1986-12-31 1990-09-11 Ciba Corning Diagnostics Corp. Complement stabilization
US5238845A (en) * 1991-08-02 1993-08-24 Instrumentation Laboratory S.P.A. Method for producing a co2 calibration liquid
US5385844A (en) * 1993-04-22 1995-01-31 Boehringer Mannheim Corporation Polymer containing control reagents and polymers useful in control reagents
US6268481B1 (en) 1997-05-29 2001-07-31 Medical Analysis Systems, Inc. Covalently coupled troponin complexes
US11634257B2 (en) 2017-10-09 2023-04-25 Terumo Bct Biotechnologies, Llc Lyophilization container and method of using same
US11604026B2 (en) 2019-03-14 2023-03-14 Terumo Bct Biotechnologies, Llc Lyophilization loading tray assembly and system
US11609042B2 (en) 2019-03-14 2023-03-21 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use
US11740019B2 (en) 2019-03-14 2023-08-29 Terumo Bct Biotechnologies, Llc Lyophilization loading tray assembly and system
US11747082B2 (en) 2019-03-14 2023-09-05 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use
US11815311B2 (en) 2019-03-14 2023-11-14 Terumo Bct Biotechnologies, Llc Lyophilization container fill fixture, system and method of use

Similar Documents

Publication Publication Date Title
US3629142A (en) Reference standard blood serum for the calibration of automatic blood serum analyzing apparatus
US3466249A (en) Blood serum reference standard for multi-automated analytical procedures
SU1501929A3 (en) Method of analysis of whole blood sample
US4121905A (en) Process for preparing biological compositions for use as reference controls in diagnostic analyses
US3682835A (en) Liquid blood serum control standard
US4189401A (en) Method of storing a biological reference control standard and biological reference control standard obtained thereby
US4317879A (en) Glucose analyzer membrane containing immobilized glucose oxidase
CN111707631A (en) Preparation method of reagent ball for urea determination, reagent ball and detection chip
US3728226A (en) Blood serum analytical control standard
US3527674A (en) Reagent material and method for urea assay
US4301028A (en) Control reagent for heparin activity determination
US4141856A (en) Reference material for establishing anion concentrations in analytical chemistry tests
IE46892B1 (en) A composition for use in determination methods
JPS6047695A (en) Simple method for determination of freshness-judgement constant k of fish and shellfish
US3753863A (en) Reagent for medical testing which contains a benzidine-like compound
WO2021000654A1 (en) Method for detecting heparin or heparin-like substances in blood and kit
US4833090A (en) Preservation of glucose in blood
Kuan et al. Enzymatic determination of serum urea on the surface of silicone-rubber pads
US6852540B2 (en) Control serum for dry analytical element
Ramer et al. Effects of hemolysis and frozen storage on serum electrolyte and chemistry values in cotton-top tamarins (Saguinus oedipus)
US3527331A (en) Reagent for assaying aldolase
JPH043960B2 (en)
CA1088851A (en) Reference material for establishing anion concentrations in analytical chemistry tests
US3546074A (en) Reagent for assaying glutamate oxaloacetate transaminase
US11543398B2 (en) Carbonic anhydrase-catalyzed isotope equilibrium between CO2—H2O for oxygen isotope analyses of aqueous samples

Legal Events

Date Code Title Description
AS Assignment

Owner name: COOPER LABORATORES, INC., 3145 PORTER DRIVE, PALO

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:BAXTER TRAVENOL LABORATORIES, INC., A CORP. OF DE;REEL/FRAME:004067/0785

Effective date: 19820917

AS Assignment

Owner name: TECHNICON INSTRUMENTS CORPORATION, 511 BENEDICT AV

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:COOPER LABORATORIES, INC.,;REEL/FRAME:004926/0396

Effective date: 19880628